Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis (Q33594928)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis |
scientific article |
Statements
1 reference
Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis (English)
1 reference
Tao Xu
1 reference
Juxiang Chen
1 reference
Yicheng Lu
1 reference
Johannes Ea Wolff
1 reference
2 June 2010
5 references
3 April 2019
25 April 2019
25 June 2019
23 September 2020
5 references
3 April 2019
25 April 2019
25 June 2019
23 September 2020
10
1 reference
252
1 reference
4 references
3 April 2019
25 April 2019
25 June 2019
23 September 2020
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference